ERBB2 and cancer: A meta-analysis of 61 clinical studies from Michel et al. concluded that Tn elevation is associated with cancer treatment (OR 14.3; CI 6.0–34.1), especially in the case of HER2-therapy, elevated Tn was associated with a high risk of systolic dysfunction (OR 11.9; CI 4.4–32.1).